FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Weintraub

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Physiology

Cognition

Procedures

Geriatric Assessment

Co-author Network

Publications

TOP 3
Daniel Weintraub
Neuropsychiatric symptoms in Parkinson disease and dementia with lewy bodies: what geriatric psychiatry can learn.
Daniel Weintraub; Kimberly Papay; Andrew Siderowf
Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study.
Daniel Weintraub; Melissa J Nirenberg
Impulse control and related disorders in Parkinson's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Weintraub (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniel Weintraub
Neuropsychiatric symptoms in Parkinson disease and dementia with lewy bodies: what geriatric psychiatry can learn.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2013;21(6):497-500.
2013: Daniel Weintraub; Kimberly Papay; Andrew Siderowf
Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study.
Neurology 2013;80(2):176-80.
2013: Daniel Weintraub; Melissa J Nirenberg
Impulse control and related disorders in Parkinson's disease.
Neuro-degenerative diseases 2013;11(2):63-71.
2012: Cynthia A Munro; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; Daniel Weintraub; Lea T Drye; Constantine E Frangakis; Crystal Flynn Longmire; Constantine G Lyketsos; Barbara K Martin; Curtis L Meinert; Jacobo E Mintzer
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2012;20(12):1036-44.
2012: Angela H Lee; Daniel Weintraub
Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.
Movement disorders : official journal of the Movement Disorder Society 2012;27(7):858-63.
2012: James F Morley; Alice S Chen-Plotkin; Amy Colcher; Nabila Dahodwala; John E Duda; Dana Falcone; Stacy Horn; Howard I Hurtig; Matthew B Stern; Vivianna M Van Deerlin; Daniel Weintraub; Sharon X Xie; Andrew Siderowf
Genetic influences on cognitive decline in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2012;27(4):512-8.
2012: Daniel Weintraub; Sharon X Xie; Eugenia Mamikonyan; Kimberly Papay; Judy A Shea; Andrew Siderowf
Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.
Movement disorders : official journal of the Movement Disorder Society 2012;27(2):242-7.
2012: Kevin J Manning; Christina Clarke; John E Duda; Alan Lorry; Daniel Weintraub; Jayne R Wilkinson; Paul J Moberg
Medication management and neuropsychological performance in Parkinson's disease.
The Clinical neuropsychologist 2012;26(1):45-58.
2012: Daniel Weintraub; David A Wolk; Sharon X Xie; Christopher M Clark; Christos Davatzikos; Nicole Dietz; Jimit Doshi; John E Duda; Andrew Siderowf
Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
Brain : a journal of neurology 2012;135(Pt 1):170-80.
2011: James F Morley; Andrew Siderowf; Daniel Weintraub; Eugenia Mamikonyan; Paul J Moberg; John E Duda
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2011;26(11):2051-7.
2011: Daniel Weintraub; Eugenia Mamikonyan; Peijun Chen; Rosalinda V Ignacio; Helen C Kales
Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis.
Archives of neurology 2011;68(7):899-904.
2011: Daniel Weintraub; David J Burn
Parkinson's disease: the quintessential neuropsychiatric disorder.
Movement disorders : official journal of the Movement Disorder Society 2011;26(6):1022-31.
2011: Alice S Chen-Plotkin; William T Hu; Andrew Siderowf; Daniel Weintraub; Rachel Goldmann Gross; Howard I Hurtig; Sharon X Xie; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Leo McCluskey; Lauren Elman; Vivianna M Van Deerlin; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.
Annals of neurology 2011;69(4):655-63.
2011: Daniel Weintraub; John Christopher Morgan
Both the body and brain benefit from exercise: potential win-win for Parkinson's disease patients.
Movement disorders : official journal of the Movement Disorder Society 2011;26(4):607.
2011: Kimberly Papay; Eugenia Mamikonyan; Andrew Siderowf; John E Duda; Kelly E Lyons; Rajesh Pahwa; Erika D Driver-Dunckley; Charles H Adler; Daniel Weintraub
Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability.
Parkinsonism & related disorders 2011;17(3):153-5.
2011: Daniel Weintraub
A failure to communicate: preliminary evidence for cortico-striatal dysconnection with pathological gambling in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2011;26(2):193-4.
2010: Daniel Weintraub; Mandy Sohr; Marc N Potenza; Andrew Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
Annals of neurology 2010;68(6):963-8.
2010: Hengyi Rao; Eugenia Mamikonyan; John A Detre; Andrew Siderowf; Matthew B Stern; Marc N Potenza; Daniel Weintraub
Decreased ventral striatal activity with impulse control disorders in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2010;25(11):1660-9.
2010: Emily Rosenthal; Laura Brennan; Sharon Xie; Howard I Hurtig; Joshua Milber; Daniel Weintraub; Jason Karlawish; Andrew Siderowf
Association between cognition and function in patients with Parkinson disease with and without dementia.
Movement disorders : official journal of the Movement Disorder Society 2010;25(9):1170-6.
2010: Paolo Barone; Werner Poewe; Stefan Albrecht; Catherine Debieuvre; Dan Massey; Olivier Rascol; Eduardo Tolosa; Daniel Weintraub
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Lancet neurology 2010;9(6):573-80.
2010: Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
Archives of neurology 2010;67(5):589-95.
2010: Daniel Weintraub; Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine E Frangakis; Jacobo E Mintzer; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2010;18(4):332-40.
2009: Daniel Weintraub
Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.
Parkinsonism & related disorders 2009;15 Suppl 3():S110-3.
2009: Lisa Phuong; Shalini Garg; John E Duda; Matthew B Stern; Daniel Weintraub
Involuntary emotional expression disorder (IEED) in Parkinson's disease.
Parkinsonism & related disorders 2009;15(7):511-5.
2009: Daniel Weintraub; Staci Hoops; Judy A Shea; Kelly E Lyons; Rajesh Pahwa; Erika D Driver-Dunckley; Charles H Adler; Marc N Potenza; Janis Miyasaki; Andrew Siderowf; John E Duda; Howard I Hurtig; Amy Colcher; Stacy S Horn; Matthew B Stern; Valerie Voon
Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(10):1461-7.
2009: Eugenia Mamikonyan; Paul Moberg; Andrew Siderowf; John E Duda; Thomas Ten Have; Howard I Hurtig; Matthew B Stern; Daniel Weintraub
Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.
Parkinsonism & related disorders 2009;15(3):226-31.
2009: Sarra Nazem; Andrew D Siderowf; John E Duda; Thomas Ten Have; Amy Colcher; Stacy S Horn; Paul Moberg; Jayne R Wilkinson; Howard I Hurtig; Matthew B Stern; Daniel Weintraub
Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.
Journal of the American Geriatrics Society 2009;57(2):304-8.
2008: Daniel Weintraub
Dopamine and impulse control disorders in Parkinson's disease.
Annals of neurology 2008;64 Suppl 2():S93-100.
2008: Sarra Nazem; Andrew Siderowf; John E Duda; Gregory K Brown; Tom Ten Have; Matthew B Stern; Daniel Weintraub
Suicidal and death ideation in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(11):1573-9.
2008: Katherine Oehlberg; Frances K Barg; Gregory K Brown; Donna Taraborelli; Matthew B Stern; Daniel Weintraub
Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study.
Journal of geriatric psychiatry and neurology 2008;21(2):123-32.
2008: Daniel Weintraub; Cynthia L Comella; Stacy Horn
Parkinson's disease--Part 3: Neuropsychiatric symptoms.
The American journal of managed care 2008;14(2 Suppl):S59-69.
2008: Daniel Weintraub; Cynthia L Comella; Stacy Horn
Parkinson's disease--Part 2: Treatment of motor symptoms.
The American journal of managed care 2008;14(2 Suppl):S49-58.
2008: Daniel Weintraub; Cynthia L Comella; Stacy Horn
Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.
The American journal of managed care 2008;14(2 Suppl):S40-8.
2008: Eugenia Mamikonyan; Andrew Siderowf; John E Duda; Marc N Potenza; Stacy Horn; Matthew B Stern; Daniel Weintraub
Long-term follow-up of impulse control disorders in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(1):75-80.
2007: Daniel Weintraub; Howard I Hurtig
Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
The American journal of psychiatry 2007;164(10):1491-8.
2007: Daniel Weintraub; Sharon Xie; Jason H T Karlawish; Andrew Siderowf
Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15).
International journal of geriatric psychiatry 2007;22(10):1025-30.
2007: Paul Moberg; Catherine C Balderston; Jacqueline H Rick; David R Roalf; Daniel Weintraub; Galit Kleiner-Fisman; Matthew B Stern; John E Duda
Phenylthiocarbamide (PTC) perception in Parkinson disease.
Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2007;20(3):145-8.
2007: Daniel Weintraub; Kirsten Saboe; Matthew B Stern
Effect of age on geriatric depression scale performance in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(9):1331-5.
2007: Daniel Weintraub; Matthew B Stern
Intervening in the neuropsychiatric features of Parkinson's disease.
Expert review of neurotherapeutics 2007;7(6):699-710.
2007: Daniel Weintraub; Matthew B Stern
Disorders of mood and affect in Parkinson's disease.
Handbook of clinical neurology 2007;83():421-33.
2006: Daniel Weintraub; Knashawn H Morales; John E Duda; Paul Moberg; Matthew B Stern
Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease.
Parkinsonism & related disorders 2006;12(7):427-31.
2006: Daniel Weintraub; Andrew Siderowf; Marc N Potenza; Joseph S Goveas; Knashawn H Morales; John E Duda; Paul Moberg; Matthew B Stern
Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Archives of neurology 2006;63(7):969-73.
2006: Daniel Weintraub; Marc N Potenza
Impulse control disorders in Parkinson's disease.
Current neurology and neuroscience reports 2006;6(4):302-6.
2006: Daniel Weintraub; Katherine A Oehlberg; Ira R Katz; Matthew B Stern
Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(2):169-75.
2006: Daniel Weintraub; Mark S Cary; Matthew B Stern; Donna Taraborelli; Ira R Katz
Daily affect in Parkinson disease is responsive to life events and motor symptoms.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(2):161-8.
2006: Daniel Weintraub; Donna Taraborelli; Knashawn H Morales; John E Duda; Ira R Katz; Matthew B Stern
Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.
The Journal of neuropsychiatry and clinical neurosciences 2006;18(3):377-83.
2005: Daniel Weintraub; Ira R Katz
Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
The Psychiatric clinics of North America 2005;28(4):941-83, ix-x.
2005: Daniel Weintraub; Matthew B Stern
Psychiatric complications in Parkinson disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(10):844-51.
2005: Kelvin Lin-Yu Chou; Howard I Hurtig; Jurg L Jaggi; Gordon H Baltuch; Rodney J Pelchat; Daniel Weintraub
Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.
Parkinsonism & related disorders 2005;11(6):403-6.
2005: Daniel Weintraub; Knashawn H Morales; Paul Moberg; Warren B Bilker; Catherine C Balderston; John E Duda; Ira R Katz; Matthew B Stern
Antidepressant studies in Parkinson's disease: a review and meta-analysis.
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1161-9.
2005: Andrew Siderowf; Andrew B Newberg; Kelvin Lin-Yu Chou; M Lloyd; Amy Colcher; Howard I Hurtig; Matthew B Stern; Richard Doty; P David Mozley; Nancy Wintering; John E Duda; Daniel Weintraub; Paul Moberg
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.
Neurology 2005;64(10):1716-20.
2005: Daniel Weintraub; Andrew B Newberg; Mark S Cary; Andrew Siderowf; Paul Moberg; Galit Kleiner-Fisman; John E Duda; Matthew B Stern; David Mozley; Ira R Katz
Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(2):227-32.
2005: Daniel Weintraub
Therapeutic options for emotional lability: current and emerging treatments.
The American journal of geriatric pharmacotherapy 2005;3 Suppl A():12-5; quiz 16-7.
2005: Daniel Weintraub; Paul Moberg; William C Culbertson; John E Duda; Ira R Katz; Matthew B Stern
Dimensions of executive function in Parkinson's disease.
Dementia and geriatric cognitive disorders 2005;20(2-3):140-4.
2004: Daniel Weintraub; Paul Moberg; William C Culbertson; John E Duda; Matthew B Stern
Evidence for impaired encoding and retrieval memory profiles in Parkinson disease.
Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2004;17(4):195-200.
2004: Daniel Weintraub; Paul Moberg; John E Duda; Ira R Katz; Matthew B Stern
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
Journal of the American Geriatrics Society 2004;52(5):784-8.
2004: William C Culbertson; Paul Moberg; John E Duda; Matthew B Stern; Daniel Weintraub
Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel.
Assessment 2004;11(1):27-39.
2003: Nicholas Hoeh; Laszlo Gyulai; Daniel Weintraub; Joel E Streim
Pharmacologic management of psychosis in the elderly: a critical review.
Journal of geriatric psychiatry and neurology 2003;16(4):213-8.
2003: Daniel Weintraub; Paul Moberg; John E Duda; Ira R Katz; Matthew B Stern
Recognition and treatment of depression in Parkinson's disease.
Journal of geriatric psychiatry and neurology 2003;16(3):178-83.
2003: David W Oslin; Thomas R Ten Have; Joel E Streim; Catherine J Datto; Daniel Weintraub; Suzanne DiFilippo; Ira R Katz
Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents.
The Journal of clinical psychiatry 2003;64(8):875-82.
2003: Daniel Weintraub; Joel E Streim; Catherine J Datto; Ira R Katz; Suzanne DiFilippo; David W Oslin
Effect of increasing the dose and duration of sertraline trial in the treatment of depressed nursing home residents.
Journal of geriatric psychiatry and neurology 2003;16(2):109-11.
2002: Daniel Weintraub; Catherine J Datto; Joel E Streim; Ira R Katz
Second-generation issues in the management of depression in nursing homes.
Journal of the American Geriatrics Society 2002;50(12):2100-1; author reply 2101.
2002: Daniel Weintraub; Michelle Spurlock
Change in the rate of restraint use and falls on a psychogeriatric inpatient unit: impact of the health care financing administration's new restraint and seclusion standards for hospitals.
Journal of geriatric psychiatry and neurology 2002;15(2):91-4.